Found: 1
Select item for more details and to access through your institution.
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group.
- Published in:
- 2008
- By:
- Publication type:
- journal article